Role of chemokines in regulation of immunity against leishmaniasis

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 389-396

  Oghumu, Steve ^a   Lezama Dávila, Claudio M ^a   Isaac Márquez, Angelica P ^b   Satoskar, Abhay R ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSIDAD AUTÓNOMA DE CAMPECHE   (Mexico)

Author keywords

Amastigotes; Chemokine receptors; Chemokines; Granuloma; Leishmania; Promastigotes; Splenomegaly

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; AMASTIGOTE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; IMMUNOREGULATION; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS; ANIMAL; DISEASE MODEL; HUMAN; IMMUNOLOGY; LEISHMANIA; PHYSIOLOGY;

ANIMALS; CHEMOKINES; DISEASE MODELS, ANIMAL; HUMANS; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; RECEPTORS, CHEMOKINE;

EID: 77956237056     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.02.010     Document Type: Article

References (81)

1. Aga E., Katschinski D.M., van Zandbergen G., Laufs H., Hansen B., Muller K., Solbach W., Laskay T. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. Journal of Immunology (Baltimore, Md.: 1950) 2002, 169:898-905.
2. Alexander J., Satoskar A.R., Russell D.G. Leishmania species: models of intracellular parasitism. Journal of Cell Science 1999, 112(8):2993-3002.
3. Allavena P., Bianchi G., Zhou D., van Damme J., Jilek P., Sozzani S., Mantovani A. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. European Journal of Immunology 1994, 24:3233-3236.
4. Antoniazi S., Price H.P., Kropf P., Freudenberg M.A., Galanos C., Smith D.F., Muller I. Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major. Infection and Immunity 2004, 72:5168-5174.
5. Ato M., Stager S., Engwerda C.R., Kaye P.M. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nature Immunology 2002, 3:1185-1191.
6. Ato M., Nakano H., Kakiuchi T., Kaye P.M. Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. Journal of Immunology (Baltimore, Md.: 1950) 2004, 173:4815-4820.
7. Ato M., Maroof A., Zubairi S., Nakano H., Kakiuchi T., Kaye P.M. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. Journal of Immunology (Baltimore, Md.: 1950) 2006, 176:5486-5493.
8. Awasthi A., Mathur R.K., Saha B. Immune response to Leishmania infection. The Indian Journal of Medical Research 2004, 119:238-258.
9. Badolato R., Sacks D.L., Savoia D., Musso T. Leishmania major: infection of human monocytes induces expression of IL-8 and MCAF. Experimental Parasitology 1996, 82:21-26.
10. Barbi J., Brombacher F., Satoskar A.R. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation. Journal of Immunology (Baltimore, Md.: 1950) 2008, 181:4613-4620.
11. Barbi J., Oghumu S., Rosas L.E., Carlson T., Lu B., Gerard C., Lezama-Davila C.M., Satoskar A.R. Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani. The Journal of Infectious Diseases 2007, 195:1713-1717.
12. Bhattacharyya S., Dey R., Majumder N., Bhattacharjee S., Majumdar S. A novel approach to regulate experimental visceral leishmaniasis in murine macrophages using CCR5 siRNA. Scandinavian Journal of Immunology 2008, 67:345-353.
13. Bhattacharyya S., Ghosh S., Dasgupta B., Mazumder D., Roy S., Majumdar S. Chemokine-induced leishmanicidal activity in murine macrophages via the generation of nitric oxide. The Journal of Infectious Diseases 2002, 185:1704-1708.
14. Brandonisio O., Panaro M.A., Fumarola I., Sisto M., Leogrande D., Acquafredda A., Spinelli R., Mitolo V. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clinical and Experimental Medicine 2002, 2:125-129.
15. Buates S., Matlashewski G. General suppression of macrophage gene expression during Leishmania donovani infection. Journal of Immunology (Baltimore, Md.: 1950) 2001, 166:3416-3422.
16. + T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. The Journal of Infectious Diseases 2006, 193:1313-1322.
17. Cotterell S.E., Engwerda C.R., Kaye P.M. Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent manner. European Journal of Immunology 1999, 29:203-214.
18. Dasgupta B., Roychoudhury K., Ganguly S., Akbar M.A., Das P., Roy S. Infection of human mononuclear phagocytes and macrophage-like THP1 cells with Leishmania donovani results in modulation of expression of a subset of chemokines and a chemokine receptor. Scandinavian Journal of Immunology 2003, 57:366-374.
19. Del Rio L., Bennouna S., Salinas J., Denkers E.Y. CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. Journal of Immunology (Baltimore, Md.: 1950) 2001, 167:6503-6509.
20. Dey R., Majumder N., Bhattacharyya Majumdar S., Bhattacharjee S., Banerjee S., Roy S., Majumdar S. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Scandinavian Journal of Immunology 2007, 66:671-683.
21. Dey R., Sarkar A., Majumder N., Bhattacharyya Majumdar S., Roychoudhury K., Bhattacharyya S., Roy S., Majumdar S. Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis. Infection and Immunity 2005, 73:8334-8344.
22. Engwerda C.R., Ato M., Kaye P.M. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends in Parasitology 2004, 20:524-530.
23. Engwerda C.R., Ato M., Cotterell S.E., Mynott T.L., Tschannerl A., Gorak-Stolinska P.M., Kaye P.M. A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. The American Journal of Pathology 2002, 161:429-437.
24. Gu L., Tseng S., Horner R.M., Tam C., Loda M., Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000, 404:407-411.
25. Hailu A., van der Poll T., Berhe N., Kager P.A. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. The American Journal of Tropical Medicine and Hygiene 2004, 71:561-567.
26. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:7011-7015.
27. Ji J., Sun J., Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infection and Immunity 2003, 71:4278-4288.
28. Jones E., Price D.A., Dahm-Vicker M., Cerundolo V., Klenerman P., Gallimore A. The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells. Immunology 2003, 109:68-75.
29. Katzman S.D., Fowell D.J. Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site. The Journal of Clinical Investigation 2008, 118:801-811.
30. Kaye P.M., Curry A.J., Blackwell J.M. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. Journal of Immunology (Baltimore, Md.: 1950) 1991, 146:2763-2770.
31. Laufs H., Muller K., Fleischer J., Reiling N., Jahnke N., Jensenius J.C., Solbach W., Laskay T. Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors. Infection and Immunity 2002, 70:826-835.
32. Lechner A., Ritter U., Varona R., Marquez G., Bogdan C., Korner H. Protective immunity and delayed type hypersensitivity reaction are uncoupled in experimental Leishmania major infection of CCR6-negative mice. Microbes and Infection/Institut Pasteur 2007, 9:291-299.
33. Lehmann J., Enssle K.H., Lehmann I., Emmendorfer A., Lohmann-Matthes M.L. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Journal of Interferon and Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 2000, 20:63-77.
34. Liu L., Callahan M.K., Huang D., Ransohoff R.M. Chemokine receptor CXCR3: an unexpected enigma. Current Topics in Developmental Biology 2005, 68:149-181.
35. Lo S.K., Bovis L., Matura R., Zhu B., He S., Lum H., Turco S.J., Ho J.L. Leishmania lipophosphoglycan reduces monocyte transendothelial migration: modulation of cell adhesion molecules, intercellular junctional proteins, and chemoattractants. Journal of Immunology (Baltimore, Md.: 1950) 1998, 160:1857-1865.
36. Malla N., Mahajan R.C. Pathophysiology of visceral leishmaniasis - some recent concepts. The Indian Journal of Medical Research 2006, 123:267-274.
37. Mannheimer S.B., Hariprashad J., Stoeckle M.Y., Murray H.W. Induction of macrophage antiprotozoal activity by monocyte chemotactic and activating factor. FEMS Immunology and Medical Microbiology 1996, 14:59-61.
38. Matte C., Olivier M. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. The Journal of Infectious Diseases 2002, 185:673-681.
39. Melby P.C., Chandrasekar B., Zhao W., Coe J.E. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. Journal of Immunology (Baltimore, Md.: 1950) 2001, 166:1912-1920.
40. Melby P.C., Tabares A., Restrepo B.I., Cardona A.E., McGuff H.S., Teale J.M. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Experimental Parasitology 2001, 99:17-25.
41. Moll H. The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis. Behring Institute Mitteilungen 1997, 99:73-78.
42. Moser B., Willimann K. Chemokines: role in inflammation and immune surveillance. Annals of the Rheumatic Diseases 2004, 63(Suppl. 2):ii84-ii89.
43. Muller K., Bischof S., Sommer F., Lohoff M., Solbach W., Laskay T. Differential production of macrophage inflammatory protein 1gamma (MIP-1gamma), lymphotactin, and MIP-2 by CD4(+) Th subsets polarized in vitro and in vivo. Infection and Immunity 2003, 71:6178-6183.
44. Muller K., van Zandbergen G., Hansen B., Laufs H., Jahnke N., Solbach W., Laskay T. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Medical Microbiology and Immunology 2001, 190:73-76.
45. Murray H.W. Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. The Journal of Infectious Diseases 1997, 175:1477-1479.
46. Panaro M.A., Spinelli R., Lisi S., Sisto M., Acquafredda A., Fumarola L., Mitolo V., Brandonisio O. Reduced expression of the chemokine receptor CCR1 in human macrophages and U-937 cells in vitro infected with Leishmania infantum. Clinical and Experimental Medicine 2004, 3:225-230.
47. Quinones M.P., Estrada C.A., Jimenez F., Martinez H., Willmon O., Kuziel W.A., Ahuja S.K., Ahuja S.S. CCL2-independent role of CCR2 in immune responses against Leishmania major. Parasite Immunology 2007, 29:211-217.
48. Racoosin E.L., Beverley S.M. Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Experimental Parasitology 1997, 85:283-295.
49. Reiner S.L., Locksley R.M. The regulation of immunity to Leishmania major. Annual Review of Immunology 1995, 13:151-177.
50. Ritter U., Moll H. Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. European Journal of Immunology 2000, 30:3111-3120.
51. Ritter U., Korner H. Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunology 2002, 24:295-301.
52. Ritter U., Moll H., Laskay T., Brocker E., Velazco O., Becker I., Gillitzer R. Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis. The Journal of Infectious Diseases 1996, 173:699-709.
53. Rodriguez-Sosa M., Rosas L.E., Terrazas L.I., Lu B., Gerard C., Satoskar A.R. CC chemokine receptor 1 enhances susceptibility to Leishmania major during early phase of infection. Immunology and Cell Biology 2003, 81:114-120.
54. Rollins B.J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991, 78:1112-1116.
55. Romao P.R., Da Costa Santiago H., Ramos C.D., De Oliveira C.F., Monteiro M.C., De Queiroz Cunha F., Vieira L.Q. Mast cell degranulation contributes to susceptibility to Leishmania major. Parasite Immunology 2009, 31:140-146.
56. Rosas L.E., Barbi J., Lu B., Fujiwara Y., Gerard C., Sanders V.M., Satoskar A.R. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection. European Journal of Immunology 2005, 35:515-523.
57. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annual Review of Immunology 2004, 22:891-928.
58. Rousseau D., Demartino S., Anjuere F., Ferrua B., Fragaki K., Le Fichoux Y., Kubar J. Sustained parasite burden in the spleen of Leishmania infantum-infected BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge. European Cytokine Network 2001, 12:340-347.
59. Santiago H.C., Oliveira C.F., Santiago L., Ferraz F.O., de Souza D.G., de-Freitas L.A., Afonso L.C., Teixeira M.M., Gazzinelli R.T., Vieira L.Q. Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infection and Immunity 2004, 72:4918-4923.
60. Sato N., Ahuja S.K., Quinones M., Kostecki V., Reddick R.L., Melby P.C., Kuziel W.A., Ahuja S.S. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. The Journal of Experimental Medicine 2000, 192:205-218.
61. Sato N., Kuziel W.A., Melby P.C., Reddick R.L., Kostecki V., Zhao W., Maeda N., Ahuja S.K., Ahuja S.S. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice. Journal of Immunology (Baltimore, Md.: 1950) 1999, 163:5519-5525.
62. Satoskar A., Bluethmann H., Alexander J. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infection and Immunity 1995, 63:4894-4899.
63. Squires K.E., Schreiber R.D., McElrath M.J., Rubin B.Y., Anderson S.L., Murray H.W. Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. Journal of Immunology (Baltimore, Md.: 1950) 1989, 143:4244-4249.
64. Stager S., Alexander J., Carter K.C., Brombacher F., Kaye P.M. Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity. Infection and Immunity 2003, 71:4804-4807.
65. Stanley A.C., Engwerda C.R. Balancing immunity and pathology in visceral leishmaniasis. Immunology and Cell Biology 2007, 85:138-147.
66. Steigerwald M., Moll H. Leishmania major modulates chemokine and chemokine receptor expression by dendritic cells and affects their migratory capacity. Infection and Immunity 2005, 73:2564-2567.
67. Svensson M., Zubairi S., Maroof A., Kazi F., Taniguchi M., Kaye P.M. Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection. Infection and Immunity 2005, 73:7541-7547.
68. Teixeira C.R., Teixeira M.J., Gomes R.B., Santos C.S., Andrade B.B., Raffaele-Netto I., Silva J.S., Guglielmotti A., Miranda J.C., Barral A., Brodskyn C., Barral-Netto M. Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment. Journal of Immunology (Baltimore, Md.: 1950) 2005, 175:8346-8353.
69. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends in Parasitology 2006, 22:32-40.
70. Tumang M.C., Keogh C., Moldawer L.L., Helfgott D.C., Teitelbaum R., Hariprashad J., Murray H.W. Role and effect of TNF-alpha in experimental visceral leishmaniasis. Journal of Immunology (Baltimore, Md.: 1950) 1994, 153:768-775.
71. van Zandbergen G., Hermann N., Laufs H., Solbach W., Laskay T. Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes. Infection and Immunity 2002, 70:4177-4184.
72. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. Journal of Immunology (Baltimore, Md.: 1950) 2004, 173:6521-6525.
73. Vasquez R.E., Soong L. CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice. Infection and Immunity 2006, 74:6769-6777.
74. + T-cell functions during Leishmania amazonensis infection. Infection and Immunity 2008, 76:161-169.
75. Venuprasad K., Banerjee P.P., Chattopadhyay S., Sharma S., Pal S., Parab P.B., Mitra D., Saha B. Human neutrophil-expressed CD28 interacts with macrophage B7 to induce phosphatidylinositol 3-kinase-dependent IFN-gamma secretion and restriction of Leishmania growth. Journal of Immunology (Baltimore, Md.: 1950) 2002, 169:920-928.
76. Vester B., Muller K., Solbach W., Laskay T. Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infection and Immunity 1999, 67:3155-3159.
77. Viola A., Luster A.D. Chemokines and their receptors: drug targets in immunity and inflammation. Annual Review of Pharmacology and Toxicology 2008, 48:171-197.
78. Wilson M.E., Sandor M., Blum A.M., Young B.M., Metwali A., Elliott D., Lynch R.G., Weinstock J.V. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. Journal of Immunology (Baltimore, Md.: 1950) 1996, 156:2231-2239.
79. + regulatory T cells to sites of Leishmania major infection favors pathogen persistence. The Journal of Experimental Medicine 2006, 203:2451-2460.
80. Zaph C., Scott P. Interleukin-12 regulates chemokine gene expression during the early immune response to Leishmania major. Infection and Immunity 2003, 71:1587-1589.
81. Zer R., Yaroslavski I., Rosen L., Warburg A. Effect of sand fly saliva on Leishmania uptake by murine macrophages. International Journal for Parasitology 2001, 31:810-814.